Detalhe da pesquisa
1.
Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial.
Int J Gynecol Cancer
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38724236
2.
Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study.
Int J Gynecol Cancer
; 33(8): 1253-1259, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37072323
3.
The role of vascular endothelial growth factor inhibitors in the treatment of epithelial ovarian cancer.
Br J Cancer
; 126(6): 851-864, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716396
4.
A first-in-human Phase I dose-escalation trial of the novel therapeutic peptide, ALM201, demonstrates a favourable safety profile in unselected patients with ovarian cancer and other advanced solid tumours.
Br J Cancer
; 127(1): 92-101, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568736
5.
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?
Br J Cancer
; 127(1): 163-167, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35260807
6.
c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial.
BMC Med
; 20(1): 59, 2022 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35144591
7.
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
Lancet Oncol
; 22(2): 277-288, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33357510
8.
Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study.
BMC Cancer
; 21(1): 354, 2021 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794823
9.
ICON 9-an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy.
Int J Gynecol Cancer
; 31(1): 134-138, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097567
10.
Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A multi-centre, phase 1b and open-label, randomised phase 2 trial.
Gynecol Oncol
; 156(3): 545-551, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31932108
11.
First-Line Management of Advanced High-Grade Serous Ovarian Cancer.
Curr Oncol Rep
; 22(6): 64, 2020 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32494876
12.
Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases.
J Med Genet
; 56(5): 301-307, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30683677
13.
High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum.
Cancer
; 125(16): 2772-2781, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31154673
14.
Dynamics of circulating vascular endothelial growth factor-A predict benefit from antiangiogenic cediranib in metastatic or recurrent cervical cancer patients.
Br J Clin Pharmacol
; 85(8): 1781-1789, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30980733
15.
Dose-dense cisplatin with gemcitabine for relapsed platinum-resistant ovarian cancer.
Int J Gynecol Cancer
; 29(2): 341-345, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30674568
16.
Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study.
BMC Nephrol
; 20(1): 380, 2019 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31640599
17.
Palliative home parenteral nutrition in patients with ovarian cancer and malignant bowel obstruction: experiences of women and family caregivers.
BMC Palliat Care
; 18(1): 120, 2019 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31884962
18.
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.
Lancet Oncol
; 19(12): 1680-1687, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413383
19.
Assessment and management of diarrhea following VEGF receptor TKI treatment in patients with ovarian cancer.
Gynecol Oncol
; 150(1): 173-179, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29627080
20.
An Outpatient, Dose-Intense, Intravenous Cisplatin and Oral Etoposide Regimen for the Treatment of Advanced, Platinum-Resistant Ovarian Cancer.
Int J Gynecol Cancer
; 28(3): 448-452, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29466253